Journal Watch · Nature · 2026

Antiviral immunity via telomerase-like reverse transcription in bacteria.

Together with earlier studies of DRT2, DRT3, and DRT9<sup>3-5</sup>, our findings identify a conserved mechanistic logic underlying RNA-templated DNA repeat addition across diverse DRTs, despite vastly different architectural solutions, and expand the repertoire of reverse transcription-based strategies for antiviral immunity in bacteria.

Tang S, Ramirez JL, He Q et al.Nature3 min readPharma relevance 40/100

DOI: 10.1038/s41586-026-11250-8PMID: 42863825Study type: research study

TL;DR

Together with earlier studies of DRT2, DRT3, and DRT9<sup>3-5</sup>, our findings identify a conserved mechanistic logic underlying RNA-templated DNA repeat addition across diverse DRTs, despite vastly different architectural solutions, and expand the repertoire of reverse transcription-based strategies for antiviral immunity in bacteria.

Key findings

  • This mode of iterative, boundary-delimited cDNA synthesis exhibits direct parallels to the mechanism of telomeric repeat addition by eukaryotic telomerase, and phylogenetic analyses of RTs across domains of life place telomerase in a monophyletic clade with the DRT family, suggesting a common origin for their DNA polymerization activities.
  • Together with earlier studies of DRT2, DRT3, and DRT9<sup>3-5</sup>, our findings identify a conserved mechanistic logic underlying RNA-templated DNA repeat addition across diverse DRTs, despite vastly different architectural solutions, and expand the repertoire of reverse transcription-based strategies for antiviral immunity in bacteria.

What they did

Reverse transcription is templated by a defined ncRNA region with a characteristic sequence pattern and template boundary elements, both of which are conserved and essential for DNA repeat addition. Cryo-EM reconstructions reveal an unanticipated 2:1 architecture, wherein two RT monomers bind opposite sides of a pseudo-symmetric ncRNA. Biochemical experiments further demonstrate that each RT monomer reverse transcribes the template encoded on its respective side of the ncRNA, but only one generates the long repetitive product, whose template is defined by the distance between two flanking stem-loop anchors.

Full abstract (original)

Background: Defense-associated reverse transcriptases (DRTs) employ diverse and distinctive mechanisms of cDNA synthesis to protect bacteria against viral infection<sup>1</sup>. However, the functions and mechanisms of many DRTs remain unknown<sup>2</sup>. Here we identify a new antiviral defense system, DRT10, that associates with a noncoding RNA (ncRNA) to catalyze processive, protein-primed synthesis of tandem-repeat DNA.

What they did: Reverse transcription is templated by a defined ncRNA region with a characteristic sequence pattern and template boundary elements, both of which are conserved and essential for DNA repeat addition. Cryo-EM reconstructions reveal an unanticipated 2:1 architecture, wherein two RT monomers bind opposite sides of a pseudo-symmetric ncRNA. Biochemical experiments further demonstrate that each RT monomer reverse transcribes the template encoded on its respective side of the ncRNA, but only one generates the long repetitive product, whose template is defined by the distance between two flanking stem-loop anchors.

Results & conclusions: This mode of iterative, boundary-delimited cDNA synthesis exhibits direct parallels to the mechanism of telomeric repeat addition by eukaryotic telomerase, and phylogenetic analyses of RTs across domains of life place telomerase in a monophyletic clade with the DRT family, suggesting a common origin for their DNA polymerization activities. Together with earlier studies of DRT2, DRT3, and DRT9<sup>3-5</sup>, our findings identify a conserved mechanistic logic underlying RNA-templated DNA repeat addition across diverse DRTs, despite vastly different architectural solutions, and expand the repertoire of reverse transcription-based strategies for antiviral immunity in bacteria.

Abstract © the authors / Nature (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1038/s41586-026-11250-8 · PubMed 42863825.

Why it matters for pharma & biotech

  • Relevant to General & Medicine teams tracking Nature for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Nature study find?

Together with earlier studies of DRT2, DRT3, and DRT9<sup>3-5</sup>, our findings identify a conserved mechanistic logic underlying RNA-templated DNA repeat addition across diverse DRTs, despite vastly different architectural solutions, and expand the repertoire of reverse transcription-based strategies for antiviral immunity in bacteria.

What type of study is this?

It is a research study, published in Nature in 2026. Reverse transcription is templated by a defined ncRNA region with a characteristic sequence pattern and template boundary elements, both of which are conserved and essential for DNA repeat addition.

Where can I read the original paper?

The original is at the publisher via DOI 10.1038/s41586-026-11250-8. PubMed ID: 42863825. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Tang S, Ramirez JL, He Q et al.. Antiviral immunity via telomerase-like reverse transcription in bacteria.. Nature (2026). DOI: 10.1038/s41586-026-11250-8.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/antiviral-immunity-via-telomerase-like-reverse-transcription-in-bacteria-112508/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides